These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12550788)

  • 1. In vitro comparative studies of two marketed transdermal nicotine delivery systems: Nicopatch and Nicorette.
    Olivier JC; Rabouan S; Couet W
    Int J Pharm; 2003 Feb; 252(1-2):133-40. PubMed ID: 12550788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparatus for studying in vitro drug release from medicated chewing gums.
    Kvist C; Andersson SB; Fors S; Wennergren B; Berglund J
    Int J Pharm; 1999 Oct; 189(1):57-65. PubMed ID: 10518685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
    Panda A; Sharma PK; Narasimha Murthy S
    AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
    Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
    Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drinking coffee and carbonated beverages blocks absorption of nicotine from nicotine polacrilex gum.
    Henningfield JE; Radzius A; Cooper TM; Clayton RR
    JAMA; 1990 Sep; 264(12):1560-4. PubMed ID: 2395197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a nicotine polacrilex lozenge.
    Choi JH; Dresler CM; Norton MR; Strahs KR
    Nicotine Tob Res; 2003 Oct; 5(5):635-44. PubMed ID: 14577980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapeutic options for smoking cessation. Nicotine polacrilex tablets for tobacco cessation].
    Noé S
    Med Monatsschr Pharm; 2003 Dec; 26(12):418-22. PubMed ID: 14699778
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel prolonged-release nicotine transdermal patch.
    Davaran S; Rashidi MR; Khandaghi R; Hashemi M
    Pharmacol Res; 2005 Mar; 51(3):233-7. PubMed ID: 15661573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis.
    La Count TD; Zhang Q; Murawsky M; Hao J; Ghosh P; Dave K; Raney SG; Talattof A; Kasting GB; Li SK
    AAPS J; 2020 Jun; 22(4):82. PubMed ID: 32488395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bioequivalent and effect of nicotine formulation gum on smoking cessation.
    Tundulawessa Y; Yongchaiyud P; Chutrthong W; Tundulawessa K
    J Med Assoc Thai; 2010 May; 93(5):574-9. PubMed ID: 20524443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fetuses and newborn infants exposed to Nicorette].
    Rosenberg A
    Ugeskr Laeger; 1995 Jul; 157(31):4364. PubMed ID: 7645097
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
    Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
    J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized controlled study on the effectiveness of community pharmacists' advice for smoking cessation by Nicorette--evaluation at three months after initiation].
    Mochizuki M; Hatsugaya M; Rokujoh E; Arita E; Hashiguchi M; Shimizu N; Takeuchi M; Yamamoto N; Akiba Y
    Yakugaku Zasshi; 2004 Dec; 124(12):989-95. PubMed ID: 15577269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro.
    Zhang Q; Murawsky M; LaCount T; Hao J; Kasting GB; Newman B; Ghosh P; Raney SG; Li SK
    Pharm Res; 2017 Jul; 34(7):1491-1504. PubMed ID: 28493100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of clinical use of nicorette in the treatment of tobacco smokers].
    Smirnov VK
    Probl Tuberk; 1991; (7):40-4. PubMed ID: 1754588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.
    Leischow SJ; Sachs DP; Hansen MD; Bostrom AG
    Psychopharmacology (Berl); 1995 Jan; 117(2):125-9. PubMed ID: 7753957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications.
    LaCount TD; Zhang Q; Hao J; Ghosh P; Raney SG; Talattof A; Kasting GB; Li SK
    AAPS J; 2020 May; 22(3):70. PubMed ID: 32390069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.